Evidence map›Paper›PMID 21503807›Full record

Trial reportNeurocritical care2011

A prospective randomized study to evaluate the antipyretic effect of the combination of acetaminophen and ibuprofen in neurological ICU patients.

Michael E Mullins, Matthew Empey, David Jaramillo, Sameta Sosa, Theresa Human, Michael N Diringer

2 registry-linked trialsAbstract readComparative StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Neurocritical care, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02294071 phase4unknown statusnot on this mapstarted 2014, after this paper: background citation

Prospective Comparative Study of the Efficacy of Common Antipyretic Treatments in Febrile Children

TypeinterventionalSponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sRan2014Enrolled120ConditionsFeverArmsIbuprofen, Acetaminophen
NCT03496545 phase1 / phase2completednot on this mapstarted 2018, after this paper: background citation

Efficacy of Bromocriptine to Reduce Body Temperature in Febrile Critically-ill Adults With Acute Neurologic Disease: an Open-label, Blinded Endpoint, Randomized Controlled Trial

TypeinterventionalSponsorUniversity of California, San FranciscoRan2018 to 2019Enrolled47ConditionsSubarachnoid Hemorrhage, Subdural Hematoma, Traumatic Brain Injury, Ischemic StrokeArmsBromocriptine 5 MG, Acetaminophen 650 MG
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Should we treat pyrexia? And how do we do it?Critical care (London, England) · 2016
    Review
  7. Temperature Management in the Neurointensive Care Unit.Current treatment options in neurology · 2016
    Article
  8. Review
  9. Observational
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Michael E MullinsWashington University, St. Louis, MO, USA.
Matthew Empey
David Jaramillo
Sameta Sosa
Theresa Human
Michael N Diringer
Washington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo compare the antipyretic effect of simultaneously administered acetaminophen (APAP) plus ibuprofen (IBU) to either APAP or IBU alone in critically ill febrile neurological and neurosurgical patients.

methodsThis is a prospective, three-armed, randomized controlled trial of 79 patients in the neurology/neurosurgery intensive care unit (NNICU) of a tertiary care academic hospital. Eligible patients who developed a temperature ≥38°C were randomized to receive either a single dose of APAP 975 mg, a single dose of IBU 800 mg, or a combination of both (APAP + IBU). Oral temperatures were measured hourly for 6 h following medication administration.

resultsAll three treatments decreased temperature over the 6-h period. The area under the curve (AUC) for ΔT for APAP was -3.55°C-h (95% CI -4.75 to -2.34°C-h); for IBU was -4.05°C-h (95% CI -5.16 to -2.94°C-h); and for the combination of APAP and IBU was -5.10°C-h (95% CI -6.20 to -4.01°C-h). The differences in AUC between the groups were as follows: IBU versus APAP = -0.50°C-h (P = 0.28), APAP + IBU versus IBU = -1.05°C-h (P = 0.09), and APAP + IBU versus APAP = -1.56°C-h (P = 0.03).

conclusionThe combination of IBU and APAP produces significantly greater fever control than APAP alone, with trends favoring the combination over IBU alone and IBU over APAP alone.

Indexed as

Intensive Care UnitsAcademic Medical CentersAcetaminophenAntipyreticsBody TemperatureDrug Therapy, CombinationFeverHumansIbuprofenIntracranial HemorrhagesProspective StudiesThermometersAcetaminophenAntipyreticsIbuprofen

Identifiers

PMID21503807
OpenAlexW2036089075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.